Revenue for the fourth quarter and full year 2024 was $47.5 million and $179.0 million, respectively. The MRD business, which contributed 85% of revenue in the fourth quarter and 81% of revenue in the ...

Released on Friday, February 7, the January jobs report showed resilience in the labor market with higher-than-expected wage ...

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

Of the three, SOUN is performing the worst on a year-to-date basis, down 27.8% in 2025. This could be mostly due to ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Avantor, Inc. AVTR reported fourth-quarter 2024 adjusted earnings per share (EPS) of 27 cents, up 8% from the year-ago ...

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

Clinical Trials Market OverviewThe Clinical Trials Market report delivers crucial insights into the market's growth ...

For many patients, getting ready to have surgery means getting their blood drawn, their heart rhythm checked, or having other tests in the weeks leading up to their operation.

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

Harmony Biosciences’ (HRMY) recently released growth plans and pipeline advancements have showcased the company’s dedication ...